Bacterial eye infections
Conditions
Interventions
Trade Name: Minims Povidone Iodine 5% w/v Eye Drops, Solution
Pharmaceutical Form: Eye drops, solution
INN or Proposed INN: Iodinated povidone
Other descriptive name: POVIDONE, IODINATED PH. EUR.
Conc
Sponsors
St. Olavs Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: referred to intravitreal injections, age 50 years or older, informed consent Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 30 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 120
Exclusion criteria
Exclusion criteria: Use of any eye drops or eye ointment the last 4 weeks. Any use of antibiotics og steroids the last 4 weeks. Active infection or inflammation in the eye or periorbital tissue. Diabetes mellitus type 1 or 2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To investigate which concentration of Povidone-Iodine (5% vs 0,3%) that most effectively reduces the conjunctival bacterial flora;Secondary Objective: To investigate any differences in experience/discomfort for the patients between Povidone-Iodine 5% and Povidone-Iodine 0,3%;Primary end point(s): Change in number of bacterial colonies before and after treatment with povidone-iodine;Timepoint(s) of evaluation of this end point: 1 day | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): discomfort for the patient;Timepoint(s) of evaluation of this end point: 1 day | — |
Countries
Norway
Contacts
Public ContactKlinikk for ØNH, Kjeve og øyesykdom
St Olavs Hospital
Outcome results
None listed